Literature DB >> 32304691

Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York.

Asma Tekbali1, Amos Grünebaum, Abraham Saraya1, Laurence McCullough1, Eran Bornstein1, Frank A Chervenak1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32304691      PMCID: PMC7158836          DOI: 10.1016/j.ajog.2020.04.012

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   10.693


× No keyword cloud information.

Objective

On March 2, 2020, the New York Times reported the first confirmed case of an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the state of New York to be a woman from Manhattan. In the United States, as of April 2, 2020, New York has become the state with the most SARS-CoV-2 infections and deaths. By the end of April, 2020, there have been nearly 300,000 SARS-CoV-2 infections and over 17,000 deaths in the state of New York. This study aimed to investigate the number of pregnant and nonpregnant SARS-CoV-2 and coronavirus disease 2019 (COVID-19) cases during hospital admissions in the state of New York.

Study Design

This study focused on pregnant and nonpregnant SARS-CoV-2 and COVID-19 cases during hospital admissions. We used data that were collected at a large hospital group (14 hospitals) in the state of New York between March 2, 2020, and March 29, 2020. Routine SARS-CoV-2 testing was not performed. Data included week of admission, pregnancy status of the patient, and SARS-CoV-2 status (positive or negative). Subjects were diagnosed with SARS-CoV-2 on admission, during hospital stay, and after delivery. The institutional review board (IRB) determined that this study did not meet the definition of human subject research and that no IRB review was required.

Results

The Table and Figure show the SARS-CoV-2–positive cases by pregnancy status and weeks. A total of 21,980 admissions at 14 hospitals during the 4-week period was noted. Among those admissions, 3064 were pregnant or postpartum patients, and 18,916 were nonpregnant patients.
Table

COVID-19–positive cases by pregnancy status and week

DateNot pregnantPregnantTotal
March 2–81.21% (63/5213)0.14% (1/737)1.08% (64/5950)
March 9–158.17% (409/5009)0.83% (7/845)7.11% (416/5854)
March 16–2231.46% (1295/4116)1.72% (13/756)26.80% (1306/4872)
March 23–2956.79% (2600/4578)5.65% (41/726)49.79% (2641/5304)
Total23.10% (4367/18,916)2.02% (62/3064)20.14% (4427/21,980)

Values are presented as n (%) (n/N).

COVID-19, coronavirus disease 2019.

Tekbali. Pregnant vs nonpregnant SARS-CoV-2 and COVID-19 hospital admissions in New York. Am J Obstet Gynecol 2020.

Figure

Percentage of COVID-19–positive cases during hospital admissions by status and weeks in March

COVID-19, coronavirus disease 2019.

Tekbali. Pregnant vs nonpregnant SARS-CoV-2 and COVID-19 hospital admissions in New York. Am J Obstet Gynecol 2020.

COVID-19–positive cases by pregnancy status and week Values are presented as n (%) (n/N). COVID-19, coronavirus disease 2019. Tekbali. Pregnant vs nonpregnant SARS-CoV-2 and COVID-19 hospital admissions in New York. Am J Obstet Gynecol 2020. Percentage of COVID-19–positive cases during hospital admissions by status and weeks in March COVID-19, coronavirus disease 2019. Tekbali. Pregnant vs nonpregnant SARS-CoV-2 and COVID-19 hospital admissions in New York. Am J Obstet Gynecol 2020. The SARS-CoV-2 infection status for pregnant and postpartum patients increased from 0.14% of all hospital admissions in week 1 to 5.65% of all hospital admissions in week 4 (relative risk [RR], 14.81; 95% confidence interval [CI], 2.07–107.38). The SARS-CoV-2 status for nonpregnant patients increased from 1.21% of all hospital admissions in week 1 to 56.79% of all hospital admissions in week 4 (RR, 46.99; 95% CI, 36.72–60.15).

Conclusion

In our study, after the first New York diagnosis of a SARS-CoV-2 infection, we reported a sudden influx of pregnant and nonpregnant patients with SARS-CoV-2 in a large hospital group (14 hospitals) during the first 4 weeks in the state of New York. There have been multiple publications describing the first approaches and management of pregnant women with COVID-19 and SARS-CoV-2 infection.2, 3, 4, 5 In general, there was a significant increase in COVID-19 infection cases in all hospital admissions, from 1.08% in week 1 to 49.79% in week 4. SARS-CoV-2–diagnosed cases were significantly higher among nonpregnant patients (RR, 46.99) than among pregnant patients (RR, 14.81). Furthermore, pregnant women with SARS-CoV-2 and COVID-19 had a significantly lower admission percentage than nonpregnant patients with similar infection status. The lower rate of COVID-19 infection among pregnant patients has previously been reported and is likely because of several factors. First and foremost, testing for the SARS-CoV-2 virus causing COVID-19 infection is still not universal and is reserved for symptomatic patients. Because pregnant women are younger and are less likely to contract the infection and show typical symptoms, they are less likely to get tested. In addition, hospital admissions for nonpregnant patients were for those with symptoms, whereas admissions for pregnant patients were usually for labor and delivery and not because of COVID-19 symptoms. Considering the rapid increase in SARS-CoV-2 and COVID-19 cases and the significant difference in hospital admissions between SARS-CoV-2–positive asymptomatic nonpregnant patients and SARS-CoV-2–negative asymptomatic pregnant women, hospitals may want to consider the proposal of Britain’s most senior midwife that maternity services be “ringfenced” during this crisis to ensure women’s health services continue to provide safe care and pregnant and postpartum women and their newborns continue to receive safe care without compromise. The term “ringfencing” originates from the term ring-fence, a structure built to keep farm animals in and predators out. In finance, a ring-fence is a virtual barrier that segregates a portion of an individual’s or company’s financial assets from the rest. Human and material maternity resources should be ringfenced from redeployment, to avoid impairing the capacity of labor and delivery units and to ensure that pregnant and postpartum patients and their newborns continue to receive the safest possible care.
  4 in total

1.  COVID-19 in pregnant women.

Authors:  Manuel B Schmid; Jehudith Fontijn; Nicole Ochsenbein-Kölble; Christoph Berger; Dirk Bassler
Journal:  Lancet Infect Dis       Date:  2020-03-17       Impact factor: 25.071

Review 2.  Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.

Authors:  Sonja A Rasmussen; John C Smulian; John A Lednicky; Tony S Wen; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

3.  Management of pregnant women infected with COVID-19.

Authors:  Yongwen Luo; Kai Yin
Journal:  Lancet Infect Dis       Date:  2020-03-24       Impact factor: 25.071

Review 4.  Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.

Authors:  Pradip Dashraath; Jing Lin Jeslyn Wong; Mei Xian Karen Lim; Li Min Lim; Sarah Li; Arijit Biswas; Mahesh Choolani; Citra Mattar; Lin Lin Su
Journal:  Am J Obstet Gynecol       Date:  2020-03-23       Impact factor: 8.661

  4 in total
  10 in total

1.  The impact of COVID-19 during pregnancy on maternal and neonatal outcomes: a systematic review.

Authors:  Despoina Michailidou; Androniki Stavridou; Eleni D Panagouli; Theodoros N Sergentanis; Theodora Psaltopoulou; Flora Bacopoulou; Valentina Baltag; Donald E Greydanus; George Mastorakos; George P Chrousos; Maria N Tsolia; Artemis K Tsitsika; Nikolaos Vlahos
Journal:  EMBnet J       Date:  2021-10-22

2.  The influence of structural racism, pandemic stress, and SARS-CoV-2 infection during pregnancy with adverse birth outcomes.

Authors:  Teresa Janevic; Whitney Lieb; Erona Ibroci; Jezelle Lynch; Molly Lieber; Nina M Molenaar; Anna-Sophie Rommel; Lotje de Witte; Sophie Ohrn; Juan Manuel Carreño; Florian Krammer; Lauren B Zapata; Margaret Christine Snead; Rachel I Brody; Rebecca H Jessel; Stephanie Sestito; Alan Adler; Omara Afzal; Frederieke Gigase; Roy Missall; Daniel Carrión; Joanne Stone; Veerle Bergink; Siobhan M Dolan; Elizabeth A Howell
Journal:  Am J Obstet Gynecol MFM       Date:  2022-04-21

3.  Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?

Authors:  Roger Pique-Regi; Roberto Romero; Adi L Tarca; Francesca Luca; Yi Xu; Adnan Alazizi; Yaozhu Leng; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Elife       Date:  2020-07-14       Impact factor: 8.140

4.  Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019.

Authors:  Matthew J Blitz; Amos Grünebaum; Asma Tekbali; Eran Bornstein; Burton Rochelson; Michael Nimaroff; Frank A Chervenak
Journal:  Am J Obstet Gynecol       Date:  2020-05-07       Impact factor: 8.661

Review 5.  Home Birth in the Era of COVID-19: Counseling and Preparation for Pregnant Persons Living with HIV.

Authors:  Ashish Premkumar; Irina Cassimatis; Saba H Berhie; Jennifer Jao; Susan E Cohn; Sarah H Sutton; Brianne Condron; Jordan Levesque; Patricia M Garcia; Emily S Miller; Lynn M Yee
Journal:  Am J Perinatol       Date:  2020-06-04       Impact factor: 1.862

6.  Severe Coronavirus Infections in Pregnancy: A Systematic Review.

Authors:  Romeo R Galang; Karen Chang; Penelope Strid; Margaret Christine Snead; Kate R Woodworth; Lawrence D House; Mirna Perez; Wanda D Barfield; Dana Meaney-Delman; Denise J Jamieson; Carrie K Shapiro-Mendoza; Sascha R Ellington
Journal:  Obstet Gynecol       Date:  2020-08       Impact factor: 7.623

7.  A Survey of Labor and Delivery Practices in New York City during the COVID-19 Pandemic.

Authors:  Juan A Peña; Angela T Bianco; Lynn L Simpson; Peter S Bernstein; Ashley S Roman; Dena Goffman; William E Schweizer; Jessica Overbey; Joanne L Stone
Journal:  Am J Perinatol       Date:  2020-06-09       Impact factor: 1.862

Review 8.  Pregnancy and COVID-19.

Authors:  Elizabeth A N Wastnedge; Rebecca M Reynolds; Sara R van Boeckel; Sarah J Stock; Fiona C Denison; Jacqueline A Maybin; Hilary O D Critchley
Journal:  Physiol Rev       Date:  2020-09-24       Impact factor: 37.312

9.  Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review.

Authors:  Elizabeth Centeno-Tablante; Melisa Medina-Rivera; Julia L Finkelstein; Pura Rayco-Solon; Maria Nieves Garcia-Casal; Lisa Rogers; Kate Ghezzi-Kopel; Pratiwi Ridwan; Juan Pablo Peña-Rosas; Saurabh Mehta
Journal:  Ann N Y Acad Sci       Date:  2020-08-28       Impact factor: 5.691

10.  Short-term outcomes of pregnant women with convalescent COVID-19 and factors associated with false-negative polymerase chain reaction test: A prospective cohort study.

Authors:  Orhan Sahin; Taner Yildirmak; Serap Karacalar; Emine Aydın; Mehmet Ali Ciftci; Helin Bagci; Sukran Yildirim; Cagdas Emeklioglu; Burcu Gulsah Balci; Simten Genc; Basak Cingillioglu; Veli Mihmanli; Asma Khalil; Erkan Kalafat
Journal:  Int J Clin Pract       Date:  2021-08-26       Impact factor: 3.149

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.